Edwards Lifesciences Corp

مادة اعلانية

Latest Update: 15 May 2025 23:59 Abu Dhabi Time.

Market Status: Closed

76.90

USD

0.150

0.20%

Open

76.93

Prev Close

76.75

PX_VOLUME

MARKET CAP (M)

DAY RANGE

76.11 - 77.27

52 WEEKS

58.93 - 95.25

Stock Statistics

Yearly Change

-14.73%

Listed Shares (Million)

655.90

Earnings Multiple

10.98

Average 30-day trading volume

5,045,641.13

Price-to-book ratio

4.44

Earnings Per Share

2.34

Previous Dividend Distribution

Dividend Yield

0.00%

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Revenue		1,412.70	1,385.80	1,354.40	1,385.90	1,329.90	1,266.40	1,243.40
Gross Profit		1,111.10	1,093.60	1,091.50	1,100.60	1,043.00	1,015.40	992.80
Operating Income		409.90	353.30	394.30	377.20	357.90	356.70	368.10
Net Income		363.60	345.00	362.10	366.40	324.90	333.10	334.90
Profit Margin		25.74	24.90	26.74	26.44	24.43	26.30	26.93

	Period Ending:	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Revenue		5,439.50	5,010.00	4,464.00	5,232.50	4,386.30
Gross Profit		4,322.00	4,031.60	3,740.30	3,983.60	3,305.70
Operating Income		1,480.10	1,486.20	1,539.10	1,586.80	1,316.60
Net Income		1,396.00	1,220.00	1,324.00	1,503.10	823.40
Profit Margin		25.66	24.35	29.66	28.73	18.77

Balance Sheet

	Period Ending:	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Assets		13,022.30	13,055.30	12,971.20	10,099.30	9,736.30	9,363.20	9,370.80
Total Liabilities		2,830.70	2,992.40	3,359.80	2,594.70	2,549.90	2,643.80	2,643.70
Total Equity		10,191.60	10,062.90	9,611.40	7,504.60	7,186.40	6,719.40	6,727.10

	Period Ending:	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Assets		13,055.30	9,363.20	8,292.50	8,502.60	7,237.10
Total Liabilities		2,992.40	2,643.80	2,485.80	2,666.70	2,662.80
Total Equity		10,062.90	6,719.40	5,806.70	5,835.90	4,574.30

Cash Flows Statements

	Period Ending:	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Cash From Operating Activities		280.40	-127.50	351.80	371.50	-53.50	136.60	411.50
Cash From Investing Activities		85.30	-576.70	2,701.70	124.80	63.10	14.10	89.00
Cash From Financing Activities		-258.00	28.60	-976.70	-96.60	61.70	-413.20	-143.30
Net Change in Cash		90.00	-624.60	2,025.30	429.10	81.00	-265.90	366.40

	Period Ending:	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash From Operating Activities		542.30	895.80	1,218.20	1,732.10	1,054.30
Cash From Investing Activities		2,312.90	173.80	252.30	-1,722.50	-531.10
Cash From Financing Activities		-983.00	-711.00	-1,584.50	-356.30	-486.90
Net Change in Cash		1,910.80	375.40	-94.80	-332.80	15.80

* In Million of United States Dollar

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.

Edwards Lifesciences Corp

إدواردز لايفسيانسز كورب